Industrialization of American Medicine - Data to Knowledge

Industrialization of Medicine:

The transformation of data into knowledge

Robert Bond, MBA | robert@acoadvantage.com | 484.431.3015 (mobile)

ACOAdvantage (www.acoadvantage.com)

Breakthrough Performance in the Health Reform Era ACOAdvantage

www.acoadvantage.com

Intent of this Presentation Forecast the opportunities created by the movement from

volume based care towards value based medicine

In this presentation we specifically consider the value and

uses of data in healthcare

1

Providers Vendors / Consultants Investors

Discover how the delivery

of care will change in the

years ahead

Gain a competitive advantage

and stay ahead of the curve.

Learn what the healthcare

market will demand in the

months and years ahead

Grow your investments.

Create new opportunities

through mergers, acquisitions,

and investments in new

ventures

What you will gain from this presentation

Up to 98,000 people die every year from medical errors1. That is equivalent

to one commercial jumbo jet airliner full of about 270

passengers crashing each day

Billions of dollars are lost via mistreatment, preventable illness, poor self-care,

etc

Source: (1) Institute of Medicine. 1999. To Err Is Human: Building a Safer Health Care System.

Washington, DC: National Academies Press

3

In comparison, fatalities from commercial

air travel are rare Consider that millions of passengers fly

every year yet relatively few accidents occur

Why is this?

4

Data from accidents improve

safety and reduce costs and is used to implement initiatives including new

procedures, preventative measures, design of aircraft,

training, etc

How can we apply this to healthcare?

5

Consider that a tsunami of

data is flooding the

healthcare world This data has tremendous value

What are the applications?

Electronic Medical Records

Mobile Devices (mHealth)

Public Databases

6

Applications of data

have immense financial

and societal value Remote monitoring

Healthcare expert systems

Bio-surveillance

Post-market drug surveillance

Comparative effectiveness

Quality reporting

Risk management

Root cause analysis

Pay for performance

How can I leverage this

in my organization?

Robert Bond, MBA

Partner

ACOAdvantage (www.acoadvantage.com)

robert@acoadvantage.com | 484.431.3015

Learn more Learn more by contacting us today